Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANG-3777 for Delayed Graft Function in Kidney Transplant Recipients
NCT02474667Phase 3Unknown
- Sponsor
- Angion Biomedica Corp.
- Start
- Mar 2016
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of terevalefim in delayed graft function (DGF), sponsored by Angion Biomedica Corp.. Status: unknown.
02
Drugs
terevalefim
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT02474667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474667.